Journal Articles
JACC: Heart Failure
Year : 2019
Philippe DE CARVALHO : Connect in order to contact the contributor
https://hal.univ-lorraine.fr/hal-02510373
Submitted on : Tuesday, March 17, 2020-5:13:58 PM
Last modification on : Wednesday, November 3, 2021-5:05:28 AM
Dates and versions
Identifiers
- HAL Id : hal-02510373 , version 1
- DOI : 10.1016/j.jchf.2018.11.016
- PUBMED : 30606485
Cite
Patrick Rossignol, Joao Pedro Ferreira. Balancing Benefits and Risks of Spironolactone in HFpEF and Chronic Kidney Disease Patients. JACC: Heart Failure, 2019, 7 (1), pp.33-35. ⟨10.1016/j.jchf.2018.11.016⟩. ⟨hal-02510373⟩
Collections
29
View
0
Download